Devex: New approaches needed to end TB
Anna Nakanwagi-Mukwaya, director of the International Union Against Tuberculosis and Lung Disease’s Uganda office; Paula Fujiwara, the Union’s scientific director; and Lucica Ditiu, executive secretary of the Stop TB Partnership

“…Innovative projects like [Slum Partnerships to Actively Respond to Tuberculosis in Kampala (SPARK-TB)], which build up local capacity and rely on community participation to deliver quality-assured health services, will ensure that communities are properly equipped and able to provide care and support for their own people — helping us make the necessary strides toward the elimination of TB within the next generation” (3/24).

Fox News: World Tuberculosis Day 2015: 9 million new cases a year is too many. Here’s how to change TB’s future
Tom Kenyon, director of the CDC’s Center for Global Health

“…At CDC, we work closely with many international partners to build the evidence base for better ways to prevent, find, and cure TB, including MDR-TB. … By pairing global efforts to improve public health response capabilities with proven interventions to strengthen TB control, we can come closer to this reality and stop the suffering and cost associated with this deadly disease” (3/24).

Huffington Post: Partnering Across Public and Private Sectors to Beat TB in India
Gopi Gopalakrishnan, founder and president of World Health Partners

“…In 2014, our organization, World Health Partners (WHP), launched the Universal Access to TB Care (UATBC) to save lives and reduce diagnostic delay for TB by expanding the TB care ecosystem to include private sector health care providers. This initiative, a public-private partnership with the State Government of Bihar, leverages India’s vast private sector to reduce diagnostic delay and increase the number of TB notifications in Patna…” (3/23).

Thomson Reuters Foundation: The urgent quest for new TB drugs: it’s not rocket science
Mel Spigelman, president and chief executive of the Global Alliance for TB Drug Development (TB Alliance)

“…As is true for all bacterial infections, the tuberculous bacillus will evolve and develop resistance to new drugs. With judicious use, the process of generating resistance can be slowed down, but we need to continue to expand research efforts to protect future generations of TB patients…” (3/24).

Slate: The Most Neglected Disease
Jens Erik Gould, co-founder and editor-in-chief of the Knife of Aristotle

“…If [reporters and editors] gave readers and viewers more opportunities to learn about important issues such as tuberculosis, the public might become accustomed to learning about them and, in the long term, actually seek out such news. That, in turn, could influence policymakers and donors to remember, when it comes time to write checks, those dying needlessly of TB” (3/24).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.